XML 90 R37.htm IDEA: XBRL DOCUMENT
v3.24.0.1

STOCK COMPENSATION (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Schedule of Stock Compensation Expense recorded in Consolidated Statements of Operations | The amounts of stock compensation expense recorded in the Company’s Consolidated Statements of Operations for the years ended December 31, 2023, 2022 and 2021 were as follows:
|  | Year Ended December 31,
(in millions) |  | 2023 |  | 2022 |  | 2021
Cost of products sold |  | $ | 4 |  |  | $ | 3 |  |  | $ | 3 |
Selling, general, and administrative expense |  | 36 |  |  | 53 |  |  | 44 |
Research and development expense |  | 4 |  |  | 3 |  |  | 2 |
Restructuring and other costs |  | 2 |  |  | — |  |  | — |
Total stock based compensation expense |  | $ | 46 |  |  | $ | 59 |  |  | $ | 49 |
Related deferred income tax benefit |  | $ | 8 |  |  | $ | 7 |  |  | $ | 6 |
Schedule of Assumptions Used to Determine Compensation Cost for the Company's Non-qualified Stock Options Issued | The Company uses the Black-Scholes option-pricing model to estimate the fair value of each option awarded. The average assumptions used to determine compensation cost for the Company’s NQSOs issued were as follows:
|  | Year Ended December 31,
|  | 2023 |  | 2022 |  | 2021
Weighted average fair value per share |  | $ | 12.64 |  |  | $ | 14.06 |  |  | $ | 15.90 |
Expected dividend yield |  | 1.45 | % |  | 1.09 | % |  | 0.68 | %
Risk-free interest rate |  | 4.27 | % |  | 2.23 | % |  | 0.79 | %
Expected volatility |  | 35.8 | % |  | 32.7 | % |  | 31.5 | %
Expected life (years) |  | 4.76 |  | 5.20 |  | 5.08
Schedule of Non-qualified Stock Option Transactions | The NQSO transactions for the year ended December 31, 2023 were as follows:
|  | Outstanding |  | Exercisable |  | Expected to Vest
(in millions, except per share amounts) |  | Shares |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value |  | Shares |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value |  | Shares |  | Weighted Average Exercise Price |  | Aggregate Intrinsic Value
December 31, 2022 |  | 3.0 |  |  | $ | 51.64 |  |  | $ | — |  |  | 1.9 |  |  | $ | 52.43 |  |  | $ | — |  |  | 1.1 |  |  | $ | 50.21 |  |  | $ | — |
Granted |  | 0.7 |  |  | 38.67 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercised |  | — |  |  | 39.77 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cancelled |  | (0.7) |  |  | 51.08 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited |  | (0.4) |  |  | 52.10 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
December 31, 2023 |  | 2.6 |  |  | $ | 48.11 |  |  | $ | 1 |  |  | 1.6 |  |  | $ | 52.55 |  |  | $ | — |  |  | 1.0 |  |  | $ | 41.41 |  |  | $ | 1 |
Schedule of Information about Non-qualified Stock Options Outstanding | Information about NQSOs outstanding for the year ended December 31, 2023 were as follows:
|  |  |  | Outstanding |  | Exercisable
|  | Number Outstanding at December 31, 2023 |  | Weighted Average Remaining Contractual Life (in years) |  | Weighted Average Exercise Price |  | Number Exercisable at December 31, 2023 |  | Weighted Average Exercise Price
Range of Exercise Prices |  |  |  |  |
(in millions, except per share amounts and life) |  |  |  |  |
30.01 |  | - | 40.00 |  | 0.8 |  |  | 9.1 |  | $ | 37.13 |  |  | — |  |  | $ | 30.97 |
40.01 |  | - | 50.00 |  | 0.6 |  |  | 3.7 |  | 47.32 |  |  | 0.6 |  |  | 47.50 |
50.01 |  | - | 60.00 |  | 0.9 |  |  | 4.7 |  | 55.29 |  |  | 0.7 |  |  | 55.44 |
60.01 |  | - | 70.00 |  | 0.3 |  |  | 2.5 |  | 62.33 |  |  | 0.3 |  |  | 62.29 |
|  |  |  | 2.6 |  |  |  |  |  |  | 1.6 |  |  |
Schedule of the Unvested RSU Transactions | The unvested RSU transactions for the year ended December 31, 2023 were as follows:
|  | Unvested Restricted Stock Units
|  | Shares |  | Weighted Average Grant Date Fair Value
(in millions, except per share amounts) |  |
Unvested at December 31, 2022 |  | 4.4 |  |  | $ | 45.63 |
Granted |  | 1.7 |  |  | 40.91 |
Vested |  | (0.8) |  |  | 40.04 |
Forfeited |  | (1.7) |  |  | 49.19 |
Unvested at December 31, 2023 |  | 3.6 |  |  | $ | 42.95 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Share Based Compensation Management Incentive Shares Authorized Under Stock Option Plans By Exercise Price Range [Table Text Block] + References No definition available. + Details
Name: | xray_ScheduleOfShareBasedCompensationManagementIncentiveSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock
Namespace Prefix: | xray_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share Based Compensation Options Activity Disclosure [Table Text Block] + References No definition available. + Details
Name: | xray_ShareBasedCompensationOptionsActivityDisclosureTableTextBlock
Namespace Prefix: | xray_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Unvested Restricted Stock Units Disclosure [Table Text Block] + References No definition available. + Details
Name: | xray_UnvestedRestrictedStockUnitsDisclosureTableTextBlock
Namespace Prefix: | xray_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration